Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -1.44x is 58% above its 5-year average of -3.41x, near the high end of its 5-year range (-37.30x–6.66x).
11.98% above its 12-month average of -1.64x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): -2.51x.
INTEREST COVERAGE RATIO
-1.44x
INTEREST COVERAGE RATIO AVG TTM
-1.64x
INTEREST COVERAGE RATIO AVG 3Y
-2.73x
INTEREST COVERAGE RATIO AVG 5Y
-3.41x
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+11.98%
CURRENT VS 3Y AVG
+47.27%
CURRENT VS 5Y AVG
+57.83%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-5.71x
median of 479 covered companies
CURRENT VS SECTOR MEDIAN
+74.78%
vs the sector median at left
Ardelyx, Inc.
Market Cap
$805.78M
Interest Coverage Ratio
-1.44x
TTM Avg
-1.64x
3Y Avg
-2.73x
5Y Avg
-3.41x
Market Cap
$796.60M
Interest Coverage Ratio
1.76x
TTM Avg
1.92x
3Y Avg
1.86x
5Y Avg
1.93x
Market Cap
$795.49M
Interest Coverage Ratio
-1.65x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$792.69M
Interest Coverage Ratio
N/A
TTM Avg
85.72x
3Y Avg
85.72x
5Y Avg
85.72x
Market Cap
$815.52M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$779.83M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$775.12M
Interest Coverage Ratio
-5.87x
TTM Avg
6.84x
3Y Avg
6.84x
5Y Avg
3.53x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Ardelyx, Inc. (ARDX) | $805.78M | -1.44x | -1.64x | -2.73x | -3.41x |
| InMode Ltd. (INMD)vs › | $805.78M | N/A | N/A | N/A | N/A |
| AdaptHealth Corp. (AHCO)vs › | $796.60M | 1.76x | 1.92x | 1.86x | 1.93x |
| Geron Corporation (GERN)vs › | $795.49M | -1.65x | N/A | N/A | N/A |
| Gyre Therapeutics, Inc. (GYRE)vs › | $792.69M | N/A | 85.72x | 85.72x | 85.72x |
| Jade Biosciences, Inc. (JBIO)vs › | $815.52M | N/A | N/A | N/A | N/A |
| Apnimed, Inc. (APMD)vs › | $784.52M | N/A | N/A | N/A | N/A |
| Sana Biotechnology, Inc. (SANA)vs › | $779.83M | N/A | N/A | N/A | N/A |
| Lexicon Pharmaceuticals, Inc. (LXRX)vs › | $775.12M | -5.87x | 6.84x | 6.84x | 3.53x |
| Beta Bionics, Inc. (BBNX)vs › | $839.40M | N/A | N/A | N/A | N/A |
Interest Coverage
-1.4x
Debt/Equity
1.72
Current Ratio
3.34
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -2.51x |
| 2026-03-31 | -4.74x |
| 2025-12-31 | 0.67x |
| 2025-09-30 | 0.58x |
| 2025-06-30 | -2.19x |
| 2025-03-31 | -5.80x |
| 2024-12-31 | 1.39x |
| 2024-09-30 | 0.42x |
| 2024-06-30 | -2.78x |
| 2024-03-31 | -6.08x |
| 2023-12-31 | -9.98x |
| 2023-09-30 | 3.65x |
| 2023-06-30 | -8.14x |
| 2023-03-31 | -13.05x |
| 2022-12-31 | 6.66x |
| 2022-09-30 | -12.74x |
| 2022-06-30 | -33.31x |
| 2022-03-31 | -37.27x |
| 2021-12-31 | -35.85x |
| 2021-09-30 | -34.73x |
| 2021-06-30 | -37.30x |
| 2021-03-31 | -29.10x |
| 2020-12-31 | -21.04x |
| 2020-09-30 | -14.28x |
| 2020-06-30 | -19.74x |
| 2020-03-31 | -16.04x |
| 2019-12-31 | -13.48x |
| 2019-09-30 | -15.31x |
| 2019-06-30 | -17.11x |
| 2019-03-31 | -17.78x |
| 2018-12-31 | -19.04x |
| 2018-09-30 | -16.90x |
| 2018-06-30 | -32.01x |
